Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Seres Therapeutics, Inc. (MCRB) had Non-Operating Income/Expense of $-0.55M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-40.13M |
|
-- |
|
-- |
|
$39.59M |
|
$-39.59M |
|
|
Non-Operating Income/Expense |
$-0.55M |
$-40.13M |
|
$-40.13M |
|
$-40.13M |
|
$-40.13M |
|
$-40.13M |
|
$-40.13M |
|
$-39.59M |
|
$-37.56M |
|
146.10M |
|
146.10M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$165.18M |
|
$19.11M |
|
$176.08M |
|
$341.26M |
|
$98.48M |
|
$102.01M |
|
$302.52M |
|
$401.00M |
|
$-59.74M |
|
$-59.74M |
|
$-59.74M |
|
151.44M |
|
| Cash Flow Statement Financials | |
$-35.24M |
|
$-0.06M |
|
$18.76M |
|
$136.15M |
|
$119.61M |
|
$-16.54M |
|
$6.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.68 |
|
-- |
|
-- |
|
2.41 |
|
-1.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-35.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
67.18% |
|
67.18% |
|
-11.76% |
|
-94.94% |
|
$-0.39 |
|
$-0.24 |
|
$-0.24 |
|